Crescita Therapeutics Inc.
CRRTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $18 | $24 | $17 |
| % Growth | 11.7% | -25.5% | 40.3% | – |
| Cost of Goods Sold | $10 | $7 | $10 | $7 |
| Gross Profit | $10 | $10 | $13 | $10 |
| % Margin | 49.1% | 59.1% | 56% | 59.7% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $11 | $10 | $0 | $0 |
| SG&A Expenses | $11 | $10 | $11 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $2 | $0 | $0 |
| Operating Expenses | $13 | $12 | $13 | $11 |
| Operating Income | -$3 | -$2 | $1 | -$1 |
| % Margin | -16.4% | -11.2% | 2.2% | -4.3% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$2 | $0 | -$1 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | -$3 | -$2 | $1 | -$1 |
| % Margin | -14% | -11.3% | 3.7% | -6.6% |
| EPS | -0.14 | -0.1 | 0.042 | -0.053 |
| % Growth | -40% | -339.8% | 178.4% | – |
| EPS Diluted | -0.14 | -0.098 | 0.041 | -0.053 |
| Weighted Avg Shares Out | 19 | 20 | 21 | 21 |
| Weighted Avg Shares Out Dil | 19 | 20 | 21 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $2 | $1 | $1 |
| EBITDA | -$1 | -$0 | $2 | $1 |
| % Margin | -6.8% | -2.6% | 8.5% | 3.6% |